Spots Global Cancer Trial Database for pituitary tumors
Every month we try and update this database with for pituitary tumors cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Identification of GENEtic Markers of Aggressiveness and Malignancy by Array Comparative Genomic Hybrization Analysis (CGH) | NCT01903967 | Pituitary Tumor... | 18 Years - 85 Years | Hospices Civils de Lyon | ||
| Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies | NCT01794793 | Cushing's Disea... Acromegaly Neuroendocrine ... Pituitary Tumor... Ectopic ACTH Se... Dumping Syndrom... Prostate Cancer Melanoma Negati... Melanoma Negati... | Pasireotide Cabergoline Pasireotide | 18 Years - | RECORDATI GROUP | |
| Barrow Nasal Inventory Survey | NCT01322945 | Pituitary Tumor... | 18 Years - 80 Years | St. Joseph's Hospital and Medical Center, Phoenix | ||
| Feasibility of Endosphenoidal Coil Placement for Imaging of the Sella During Transsphenoidal Surgery | NCT03678389 | Pituitary Neopl... | ESC | 18 Years - 85 Years | National Institutes of Health Clinical Center (CC) | |
| Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome | NCT00565903 | Pleuropulmonary... Cystic Nephroma Sertoli-Leydig ... Medulloepitheli... Embryonal Rhabd... Goiter Sarcoma Pineoblastoma Pituitary Tumor... Wilms Tumor | 1 Day - 95 Years | Children's National Research Institute | ||
| Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease | NCT01915303 | Cushings Diseas... | Pasireotide wit... | 18 Years - | Novartis | |
| Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly | NCT00461149 | Acromegaly | Octreotide-LAR | 18 Years - | Federico II University | |
| Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly | NCT00461149 | Acromegaly | Octreotide-LAR | 18 Years - | Federico II University | |
| Identification of GENEtic Markers of Aggressiveness and Malignancy by Array Comparative Genomic Hybrization Analysis (CGH) | NCT01903967 | Pituitary Tumor... | 18 Years - 85 Years | Hospices Civils de Lyon | ||
| Infraorbital Nerve Block for Endoscopic Transsphenoidal Approach to Remove Pituitary Tumor | NCT04785222 | Intraoperative ... | dexmedetomidine... | 18 Years - | Chiang Mai University | |
| Feasibility of Endosphenoidal Coil Placement for Imaging of the Sella During Transsphenoidal Surgery | NCT03678389 | Pituitary Neopl... | ESC | 18 Years - 85 Years | National Institutes of Health Clinical Center (CC) | |
| Identification of GENEtic Markers of Aggressiveness and Malignancy by Array Comparative Genomic Hybrization Analysis (CGH) | NCT01903967 | Pituitary Tumor... | 18 Years - 85 Years | Hospices Civils de Lyon | ||
| Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors | NCT01689727 | Pituitary Tumor... | Technetium Tc 9... | 18 Years - | Endocyte | |
| Effects of Hormone Stimulation on Brain Scans for Cushing s Disease | NCT01459237 | Pituitary Neopl... | Acthrel | 8 Years - | National Institutes of Health Clinical Center (CC) | |
| Infraorbital Nerve Block for Endoscopic Transsphenoidal Approach to Remove Pituitary Tumor | NCT04785222 | Intraoperative ... | dexmedetomidine... | 18 Years - | Chiang Mai University | |
| Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies | NCT01794793 | Cushing's Disea... Acromegaly Neuroendocrine ... Pituitary Tumor... Ectopic ACTH Se... Dumping Syndrom... Prostate Cancer Melanoma Negati... Melanoma Negati... | Pasireotide Cabergoline Pasireotide | 18 Years - | RECORDATI GROUP | |
| Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas | NCT01966809 | Brain Tumor, Re... | Photofrin photo... | 18 Years - | Medical College of Wisconsin | |
| Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome | NCT00565903 | Pleuropulmonary... Cystic Nephroma Sertoli-Leydig ... Medulloepitheli... Embryonal Rhabd... Goiter Sarcoma Pineoblastoma Pituitary Tumor... Wilms Tumor | 1 Day - 95 Years | Children's National Research Institute | ||
| Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities | NCT00054756 | Healthy Pituitary Disea... Thyroid Disease | TRH (Thyrotropi... | 2 Years - | National Institutes of Health Clinical Center (CC) | |
| Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors | NCT01682746 | Brain Tumor, Re... | Photofrin (porf... | 6 Months - 18 Years | Medical College of Wisconsin | |
| Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors | NCT01682746 | Brain Tumor, Re... | Photofrin (porf... | 6 Months - 18 Years | Medical College of Wisconsin | |
| Infraorbital Nerve Block for Endoscopic Transsphenoidal Approach to Remove Pituitary Tumor | NCT04785222 | Intraoperative ... | dexmedetomidine... | 18 Years - | Chiang Mai University | |
| Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors | NCT01682746 | Brain Tumor, Re... | Photofrin (porf... | 6 Months - 18 Years | Medical College of Wisconsin | |
| Effect of 5 Years of GH Replacement on Atherosclerosis | NCT00462475 | Hypopituitarism Pituitary Tumor... Growth Hormone ... | Recombinant Gro... | 18 Years - 50 Years | Federico II University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
